Package 72789-112-90

Brand: bupropion hydrochloride (xl)

Generic: bupropion hydrochloride
NDC Package

Package Facts

Identity

Package NDC 72789-112-90
Digits Only 7278911290
Product NDC 72789-112
Product ID 72789-112_314433f7-d500-d878-e063-6394a90adb5b
Description

90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (72789-112-90)

Marketing

Marketing Status
Marketed Since 2020-09-03
Brand bupropion hydrochloride (xl)
Generic bupropion hydrochloride
Sample Package No

Linked Drug Pages (1)

Bupropion Hydrochloride (XL) ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "314433f7-d500-d878-e063-6394a90adb5b", "openfda": {"upc": ["0372789112909"], "unii": ["ZG7E5POY8O"], "rxcui": ["993557"], "spl_set_id": ["d017f3dc-3688-487f-9130-808b33976b22"], "manufacturer_name": ["PD-Rx Pharmaceuticals, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (72789-112-90)", "package_ndc": "72789-112-90", "marketing_start_date": "20200903"}], "brand_name": "Bupropion Hydrochloride (XL)", "product_id": "72789-112_314433f7-d500-d878-e063-6394a90adb5b", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "72789-112", "generic_name": "bupropion hydrochloride", "labeler_name": "PD-Rx Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "brand_name_suffix": "(XL)", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "300 mg/1"}], "application_number": "ANDA210081", "marketing_category": "ANDA", "marketing_start_date": "20180830", "listing_expiration_date": "20261231"}